跳到正文
原文
Nature 健康护理主题·· 2026-10-21AI 评分35

结合 MCV 与 MCH 策略改善产前地中海贫血携带者检出:一项 24 年回顾性队列研究

Improving prenatal thalassemia carrier detection with a combined MCV and MCH strategy: a 24-year retrospective cohort study

AI 导读

台湾2000—2024年15,212份产前样本的回顾性队列研究显示,MCV ≤ 82 fL 或 MCH ≤ 27 pg 联合标准在男女中灵敏度均超99%,漏检率由常规 MCV ≤ 80 fL 的约5.3%降至1%以下。

正文

Scientific Reports (2026) Cite this article

We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Abstract

Carrier screening for thalassemia conventionally uses a mean corpuscular volume (MCV) cutoff ≤ 80 fL. However, silent carriers harboring mild mutations often present with borderline indices, which, if missed, may result in offspring with hemoglobin H disease or other significant hemoglobinopathies. Thus, we aimed to evaluate whether alternative hematological cutoffs could reduce this detection gap. Of 15,212 prenatal samples collected in Taiwan between 2000 and 2024, this retrospective cohort study analyzed 9,949 genetically confirmed thalassemia carriers (α-thalassemia, n = 7,473; β-thalassemia, n = 2,476) and 3,025 genotype-negative individuals, who served as the noncarrier reference group. The sensitivity and specificity of the conventional MCV threshold and alternative strategies incorporating higher MCV cutoffs and mean corpuscular hemoglobin (MCH) ≤ 27 pg were calculated and compared, stratified by sex. --SEA deletion (78.71% of α-thalassemia carriers) and IVS-II-654 mutation (34.65% of β-thalassemia carriers) were the predominant genotypes. Under the conventional MCV threshold, approximately 5.3% of carriers were missed, including 6.3% and 2.3% of α- and β-thalassemia carriers, respectively. Among the predefined candidate thresholds evaluated, the MCV ≤ 82 fL or MCH ≤ 27 pg criterion achieved sensitivity exceeding 99% in both sexes in this cohort and reduced the missed-carrier rate to < 1%, with lower specificity and more false-positive classifications. Because the preferred MCV threshold was selected after examination of the observed candidate performance, these findings are exploratory, apply to initial screening rather than diagnosis, and require prospective validation in an unselected prenatal population.

Acknowledgements

The authors would like to express their thanks to the staff of National Taiwan University Hospital-Statistical Consulting Unit (NTUH-SCU) for statistical consultation and analyses.

Funding

This study was funded by the National Taiwan University Hospital (grant number: 115-N0066).

Author information

Authors and Affiliations

  1. National Taiwan University Graduate School of Advanced Technology, Taipei, Taiwan

    Han-Ying Chen & Yi-Yun Tai

  2. Department of Obstetrics and Gynecology, National Taiwan University Hospital, No. 8, Zhongshan South Road, Zhongzheng District, Taipei, 10041, Taiwan

    Han-Ying Chen, Shin-Yu Lin, Tsang-Ming Ko & Yi-Yun Tai

  3. National Taiwan University Hospital Yun Lin Branch, Yunlin, Taiwan

    Shin-Yu Lin

  4. National Taiwan University College of Medicine Institute of Molecular Medicine, Taipei, Taiwan

    Chih-En Li

  5. Genephile Bioscience Laboratory, Ko’s Obstetrics and Gynecology, Taipei, Taiwan

    Tsang-Ming Ko

  6. Department of Medical Genetics, National Taiwan University Hospital, Taipei, Taiwan

    Qian-Hui Yang

Authors

  1. Han-Ying Chen
  2. Shin-Yu Lin
  3. Chih-En Li
  4. Tsang-Ming Ko
  5. Qian-Hui Yang
  6. Yi-Yun Tai

Corresponding author

Correspondence to Yi-Yun Tai.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, HY., Lin, SY., Li, CE. et al. Improving prenatal thalassemia carrier detection with a combined MCV and MCH strategy: a 24-year retrospective cohort study. Sci Rep (2026). https://doi.org/10.1038/s41598-026-77219-9

Download citation

  • Received: 30 April 2026

  • Accepted: 19 October 2026

  • Published: 21 October 2026

  • DOI: https://doi.org/10.1038/s41598-026-77219-9

Keywords

来源:Nature 健康护理主题 · nature.com